Biota Technology, the oilfield DNA sequencing pioneer, has achieved a critical milestone on its path to commercialization: the diagnostic has been deployed by a majority of the top 20 US shale producers in the United States.
Biota continues to attract top-tier investors, recently closing a multi-million dollar Series B financing led by Illumina Ventures.
“Biota is pioneering DNA sequencing in the energy industry,” said Ajay Kshatriya, Chief Executive Officer.
In a recently published case study, Biota delivered compelling results in the Permian Basin that uplifted the producers asset value by millions of dollars.
“We are looking forward to leveraging Biota’s new subsurface data source to potentially optimize well productivity,” said Jose Silva, Lead Business Strategist for Anadarko Petroleum Corporation.
To facilitate further commercial growth, Biota recently closed a Series B round of financing, led by Illumina Ventures.
“Biota represents an entirely novel application of next-generation DNA sequencing,” said Dr. Nick Naclerio, Founding Partner of Illumina Ventures.